6550--Cepheid GeneXpert Infinity Molecular Reagents IDIQ

Solicitation / RFP / RFQ

This document is a solicitation for Cepheid GeneXpert Infinity Molecular Reagents IDIQ (Indefinite Delivery, Indefinite Quantity). The Department of Veterans Affairs, Network Contracting Office 8 (NCO 8), is seeking to establish a contract for these reagents.

While specific technical requirements are not detailed in this excerpt, the solicitation pertains to molecular reagents for the Cepheid GeneXpert Infinity system.

• Award Number: 36C24826D0020
• Award Amount (Ceiling): $3,500,000.00
• Awardee Name: CEPHEID
• Award Date: 03-02-2026
• Contractor's UEI: W6HQTMWB9Q28
• Contractor Address: 904, EAST CARIBBEAN DRIVE, SUNNYVALE, CA 94089

Details regarding proposal submission and evaluation criteria are not provided in this excerpt.

No specific set-aside information is mentioned in this excerpt.

• Solicitation Number: 36C24826Q0193
• Product Service Code (PSC): 6550
• NAICS Code: 325413
• Contracting Office Address: Department of Veterans Affairs, Network Contracting Office 8 (NCO 8), 10,000 Bay Pines Blvd, Bay Pines FL 33744.
• Point of Contact: Moneque Rodriguez, Contracting Officer, moneque.rodriguez@va.gov, 813-972-2000.

Solicitation / RFP / RFQ

This solicitation is for the procurement and delivery of reagents for PCR testing of infectious disease agents using the Cepheid GeneXpert® Infinity Instrument for the Bay Pines VA Healthcare System. The goal is to ensure timely and accurate laboratory services to support patient care, infection control surveillance, infectious disease diagnosis, and antimicrobial stewardship.

• Procurement of specific Cepheid GeneXpert® Infinity compatible and FDA-approved reagents.

• Reagents must be specific for identified infectious disease agents including MRSA, C. difficile, CRE, CT/NG, Strep A, SARS-CoV-2, Influenza A/B, RSV, and Vaginal Infection Molecular Test.

• Vendor must provide the ability for automatic shipment on standing orders or monthly basis, as well as "As Needed" or "Emergent Overnight" shipment capabilities.

• Vendor is responsible for all shipping costs.

• Reagents must be the most current FDA-approved versions.

• For reagents with hazardous constituents, the vendor must provide information for meeting local discharge requirements.

• Contract Type: Single Award Indefinite Delivery Indefinite Quantity (IDIQ).

• Period of Performance: Ordering periods from April 1, 2026, through September 30, 2029.

• Guaranteed Minimum Award: $100,000.00.

• Maximum Aggregate Value of Orders: $3,500,000.00.

• Offers are due by February 20, 2026, 13:00 EST.

• The solicitation incorporates FAR 52.212-1, 52.212-3, and 52.212-4 by reference.

• The government intends to evaluate offers and award without discussions.

• The acquisition is unrestricted.

• NAICS Code: 325413 (In-Vitro Diagnostic Substance Manufacturing).

• Size Standard: 1250 Employees.

• This document is a solicitation (SF 1449).

• A Notice of Intent indicates the government's initial intent to negotiate a sole source contract with Cepheid, but this solicitation is being issued to determine if competitive procurement is feasible. Interested parties may submit capabilities.

Amendment / Modification

This notice updates VA Handbook 6500.6, Contract Security, specifically Appendix C, which contains VA Information and Information System Security/Privacy Language for Inclusion into Contracts. The update incorporates revised security language into Appendix C.

• VA Handbook 6500.6, Appendix C: VA Information and Information System Security/Privacy Language for Inclusion into Contracts.

This notice is effective immediately and applies to the current version of VA Handbook 6500.6 Appendix C. It does not appear to directly alter submission deadlines or evaluation criteria for any specific solicitation, but rather updates the underlying security and privacy language that may be incorporated into future or existing contracts.

Solicitation / RFP / RFQ

This document is a Sole Source Justification for the procurement of Multi-Drug Resistant Organism (MDRO) reagents for use with Cepheid GeneXpert Infinity and GeneXpert IV systems. The government anticipates a sole source, single award, firm fixed price indefinite delivery/indefinite quantity (IDIQ) contract.

• Procurement of specialized infectious disease testing reagents covering microorganisms such as MRSA, C. difficile, CP-CRE, CT/NG, Strep pyogenes, H. influenzae, and SARS-CoV2.

• Reagents are proprietary and only compatible with previously purchased Cepheid GeneXpert analyzers.

• Specific test kits include Xpert MRSA NxG, Xpert-Cdifficile/Epi, Xpert Xpress Strep A, Xpert Carba-R, Xpert CT/NG, Xpert Xpress MVP, Xpert Xpress COVID PLUS, and Xpert Xpress COV-2/FLU/RSV PLUS.

• Estimated ceiling value: $3,500,000.00

• Period of Performance: 3.5 years (Pricing Periods: April 1, 2026 - September 30, 2029)

• Contract Type: Firm Fixed Price IDIQ

• This is a sole source justification, indicating no formal proposal submission process is currently open to multiple vendors.

• The justification cites "Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements" as the reason for restricted competition.

• Not applicable as this is a sole source justification.

• The justification details extensive market research, including a sources sought synopsis, which yielded no relevant responses.

• The sole source determination is based on the proprietary nature of the reagents, compatibility with existing government-owned analyzers, and the need to avoid duplication of costs and delays in patient care.

Solicitation / RFP / RFQ

This is a Notice of Intent to solicit and negotiate a Sole Source, Fixed-Priced Single Award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Cepheid. The procurement is for a range of infectious disease testing reagents compatible with the Cepheid GeneXpert Infinity system, which is already owned by the facility. The government believes Cepheid is the only authorized provider capable of meeting the agency's needs due to the specialized nature of the supplies.

• Reagents for infectious disease testing, including but not limited to:

  • Methicillin Resistant Staph aureus (MRSA)
  • Clostridioides (Clostridium) difficile Toxin (C diff)
  • Carbapenemase Resistant Enterobacteriaceae (CRE)
  • Chlamydia trachomatis/Neisseria gonorrhoeae (CT/NG)
  • Beta hemolytic Streptococcus Group A (Streptococcus pyogenes)
  • SARS-Coronavirus-2
  • Hemophilus influenzae (influenza A and influenza B)
  • Respiratory syncytial virus (RSV)
  • Vaginal Infection Molecular Test

• Contract Type: Sole Source, Fixed-Priced Single Award IDIQ

• This notice is not a request for competitive proposals. However, interested parties may identify their interest and capability.

• Any responses received will be considered solely to determine if a competitive procurement is warranted.

• All responsible sources may submit a quotation, bid, or proposal if they believe they can meet the requirement.

• Supporting evidence of capability must be provided.

• If no responses are received, the government will proceed with the sole source acquisition.

• Responses must be emailed to Moneque Rodriguez at moneque.rodriguez@va.gov.

• Response Deadline: February 20, 2026, 13:00 PM Eastern Standard Time.

• Sole Source procurement under FAR 12.102(b) and 41 USC §1901.

• The solicitation number is 36C24826Q0193.

• The Place of Performance is the Bay Pines VA Healthcare System, Bay Pines, FL 33744.

• The NAICS Code is 325413.

• The Product Service Code is 6550.

• Contact: Moneque Rodriguez, Contracting Officer (moneque.rodriguez@va.gov, 813-972-2000).

Solicitation / RFP / RFQ

This is a Notice of Intent to solicit and negotiate a Sole Source, Fixed-Priced Single Award Indefinite Delivery Indefinite Quantity (IDIQ) contract with Cepheid. The procurement is for Multi-Drug-Resistant Organism (MDRO) reagents for use on Cepheid GeneXpert Infinity systems owned by the Department of Veterans Affairs (VA) facilities, specifically the Bay Pines VA Healthcare System and Lee County VA Clinic.

• Extensive range of Multi-Drug-Resistant Organism (MDRO) reagents.

• Reagents must be compatible with Cepheid GeneXpert Infinity systems.

• Contract Type: Sole Source, Fixed-Priced Single Award IDIQ.

• Place of Performance: Bay Pines VA Healthcare System and Lee County VA Clinic, Bay Pines, FL 33744, United States.

• This notice is not a request for competitive proposals. Any responses received will be used solely to determine if a competitive procurement is warranted.

• Interested persons must identify their interest and capability to respond.

• Supporting evidence demonstrating the ability to comply with the requirement must be provided.

• Responses should be emailed to Moneque Rodriguez at moneque.rodriguez@va.gov.

• Response Deadline: January 09, 2026, by 13:00 PM Eastern Standard Time.

• The government will not pay for information submitted.

• Sole Source procurement under FAR 12.102(a) and 41 USC §1901, as only Cepheid is believed to be capable of meeting the government's needs due to the specialized nature of the reagents.

• If no responses are received, the government will proceed with the sole source acquisition.

• Product Service Code: 6550

• NAICS Code: 325413